Published in Proc Natl Acad Sci U S A on April 29, 2008
Targeted drug delivery to tumors: myths, reality and possibility. J Control Release (2011) 2.69
Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. Angew Chem Int Ed Engl (2012) 2.08
Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J Am Chem Soc (2009) 1.67
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm (2009) 1.61
DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. Proc Natl Acad Sci U S A (2009) 1.56
A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J Control Release (2010) 1.42
Polymer-drug conjugates: origins, progress to date and future directions. Adv Drug Deliv Rev (2012) 1.28
Spectrally tunable leakage-free gold nanocontainers. J Am Chem Soc (2009) 1.14
Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles. Nat Nanotechnol (2009) 1.12
Near-infrared phosphorescent polymeric nanomicelles: efficient optical probes for tumor imaging and detection. ACS Appl Mater Interfaces (2009) 1.10
Stability of Self-Assembled Polymeric Micelles in Serum. Macromolecules (2011) 1.08
Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line. Int J Nanomedicine (2014) 1.07
Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv Drug Deliv Rev (2012) 1.05
Polymer-Based Therapeutics. Macromolecules (2009) 1.04
Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm (2013) 1.04
Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine (2013) 1.03
Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity. Bioconjug Chem (2012) 1.00
Self-assembled Tat nanofibers as effective drug carrier and transporter. ACS Nano (2013) 1.00
Kinetically controlled cellular interactions of polymer-polymer and polymer-liposome nanohybrid systems. Bioconjug Chem (2011) 0.96
Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates. ACS Nano (2012) 0.96
3-Helix micelles stabilized by polymer springs. J Am Chem Soc (2012) 0.93
Blood-stable, tumor-adaptable disulfide bonded mPEG-(Cys)4-PDLLA micelles for chemotherapy. Biomaterials (2012) 0.93
Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug release. J Control Release (2012) 0.93
Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers. Biomacromolecules (2013) 0.92
Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine. J Control Release (2010) 0.92
Aptamers selected by cell-SELEX for application in cancer studies. Bioanalysis (2010) 0.92
pH-dependent, thermosensitive polymeric nanocarriers for drug delivery to solid tumors. Biomaterials (2013) 0.91
Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. ACS Nano (2012) 0.90
Nanoparticle shape improves delivery: rational coarse grain molecular dynamics (rCG-MD) of taxol in worm-like PEG-PCL micelles. Adv Mater (2011) 0.89
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity. Int J Nanomedicine (2011) 0.87
Hydrophobic pharmaceuticals mediated self-assembly of beta-cyclodextrin containing hydrophilic copolymers: novel chemical responsive nano-vehicles for drug delivery. J Control Release (2010) 0.85
Noninvasive fluorescence resonance energy transfer imaging of in vivo premature drug release from polymeric nanoparticles. Mol Pharm (2013) 0.84
Nanomedicine for treating spinal cord injury. Nanoscale (2013) 0.84
Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review. Nano Today (2013) 0.84
Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities. Chem Eng Sci (2015) 0.83
Ligand-decorated nanogels: fast one-pot synthesis and cellular targeting. Biomacromolecules (2012) 0.83
Extracellular stability of nanoparticulate drug carriers. Arch Pharm Res (2013) 0.83
Fluorescence Imaging of Interscapular Brown Adipose Tissue in Living Mice. J Mater Chem B Mater Biol Med (2015) 0.82
Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for Bioimaging. Small (2016) 0.82
Recent advances in nanoparticle-based Förster resonance energy transfer for biosensing, molecular imaging and drug release profiling. Int J Mol Sci (2012) 0.82
PEG-PDLLA micelle treatment improves axonal function of the corpus callosum following traumatic brain injury. J Neurotrauma (2014) 0.82
FRET-enabled biological characterization of polymeric micelles. Biomaterials (2014) 0.81
FRET imaging reveals different cellular entry routes of self-assembled and disulfide bonded polymeric micelles. Mol Pharm (2013) 0.81
Effect of alkyl length of peptide-polymer amphiphile on cargo encapsulation stability and pharmacokinetics of 3-helix micelles. Biomacromolecules (2014) 0.81
Interconnected roles of scaffold hydrophobicity, drug loading, and encapsulation stability in polymeric nanocarriers. Mol Pharm (2012) 0.80
Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media. Proc Natl Acad Sci U S A (2014) 0.80
The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance. Int J Nanomedicine (2013) 0.80
Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery. Biomaterials (2016) 0.79
Poly(ethylene glycol) Corona Chain Length Controls End-Group-Dependent Cell Interactions of Dendron Micelles. Macromolecules (2014) 0.79
Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents. Am J Nucl Med Mol Imaging (2014) 0.79
Tailoring polymersome bilayer permeability improves enhanced permeability and retention effect for bioimaging. ACS Appl Mater Interfaces (2014) 0.78
Polymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide). Curr Opin Solid State Mater Sci (2012) 0.78
A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system. J Control Release (2015) 0.77
Synergism between upregulation of Rab7 and inhibition of autophagic degradation caused by mycoplasma facilitates intracellular mycoplasma infection. Mol Med Rep (2014) 0.76
Standing-wave-excited multiplanar fluorescence in a laser scanning microscope reveals 3D information on red blood cells. Sci Rep (2014) 0.76
Controlled Drug Release from Pharmaceutical Nanocarriers. Chem Eng Sci (2015) 0.76
Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation. Int J Nanomedicine (2016) 0.75
Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes. Int J Nanomedicine (2017) 0.75
PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery. Pharm Res (2013) 0.75
Controlling lipid micelle stability using oligonucleotide headgroups. J Am Chem Soc (2015) 0.75
Fluorophore exchange kinetics in block copolymer micelles with varying solvent-fluorophore and solvent-polymer interactions. Soft Matter (2016) 0.75
Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery. ACS Macro Lett (2015) 0.75
Modifying cellular properties using artificial aptamer-lipid receptors. Sci Rep (2013) 0.75
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev (2001) 10.02
Drug delivery systems: entering the mainstream. Science (2004) 9.27
Micellar nanocontainers distribute to defined cytoplasmic organelles. Science (2003) 4.37
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res (2004) 2.90
Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release (2005) 2.79
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release (2001) 2.59
Evolution of lipidic structures during model membrane fusion and the relation of this process to cell membrane fusion. Biochemistry (1997) 2.01
Quantitative coherent anti-Stokes Raman scattering imaging of lipid distribution in coexisting domains. Biophys J (2005) 1.68
Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res (1996) 1.57
Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J Control Release (2004) 1.55
Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release (2005) 1.52
Exclusion of poly(ethylene glycol) from liposome surfaces. Biochim Biophys Acta (1990) 1.36
Polymer-induced membrane fusion: potential mechanism and relation to cell fusion events. Chem Phys Lipids (1994) 1.20
Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials (2005) 1.20
Fluorescence resonance energy transfer between lipid probes detects nanoscopic heterogeneity in the plasma membrane of live cells. Biophys J (2007) 1.12
Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles. Bioconjug Chem (2002) 1.09
Interaction of phospholipid membranes with poly(ethylene glycol)s. Biochim Biophys Acta (1979) 1.04
Materials science. Enhancing drug function. Science (2003) 1.03
Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles. Biochim Biophys Acta (1999) 1.02
Movements of fluorescent probes in the mechanism of cell fusion induced by poly(ethylene glycol). J Cell Sci (1987) 0.99
An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol (1997) 0.99
The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells. Colloids Surf B Biointerfaces (2005) 0.98
Effects of poly(ethylene glycol) on liposomes and erythrocytes. Permeability changes and membrane fusion. Biochim Biophys Acta (1982) 0.96
Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes. Biochemistry (1994) 0.94
Effect of molecular weight and glass transition on relaxation and release behaviour of poly(DL-lactic acid) tablets. J Control Release (2001) 0.92
Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles in aqueous milieu. J Control Release (2002) 0.92
Lipid-polyethylene glycol interactions: II. Formation of defects in bilayers. J Membr Biol (1981) 0.89
Paclitaxel and nocodazole differentially alter endocytosis in cultured cells. Pharm Res (1996) 0.89
Cellular distribution of nonionic micelles. Science (2004) 0.89
Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro. Int J Pharm (1999) 0.89
Stability and release performance of a series of pegylated copolymeric micelles. Pharm Res (2003) 0.88
Permeation of PEO-PBLA-FITC polymeric micelles in aortic endothelial cells. Pharm Res (1999) 0.82
A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes. Biophys J (2000) 0.81
Block copolymers modify the internalization of micelle-incorporated probes into neural cells. Biochim Biophys Acta (2001) 0.80
The diploid genome sequence of an Asian individual. Nature (2008) 46.29
A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05
Antibody neutralization and escape by HIV-1. Nature (2003) 21.48
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54
The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev (2007) 13.05
Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83
TEAD mediates YAP-dependent gene induction and growth control. Genes Dev (2008) 9.88
Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol (2008) 8.92
The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94
ZDOCK: an initial-stage protein-docking algorithm. Proteins (2003) 7.52
Gene discovery and annotation using LCM-454 transcriptome sequencing. Genome Res (2006) 7.10
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01
A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet (2003) 6.82
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine (2009) 6.30
PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res (2003) 6.19
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev (2010) 6.05
SNP discovery via 454 transcriptome sequencing. Plant J (2007) 5.92
MicroRNA-mediated conversion of human fibroblasts to neurons. Nature (2011) 5.59
Multi-platform next-generation sequencing of the domestic turkey (Meleagris gallopavo): genome assembly and analysis. PLoS Biol (2010) 5.39
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev (2010) 5.38
The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30
A porous supramolecular architecture from a copper(II) coordination polymer with a 3D four-connected 8(6) net. Inorg Chem (2003) 5.16
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med (2007) 4.95
Stability of the regulatory T cell lineage in vivo. Science (2010) 4.89
Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med (2007) 4.80
Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med (2005) 4.68
The Plasmodium genome database. Nature (2002) 4.36
Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood (2003) 3.98
Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr (2004) 3.96
Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet (2006) 3.81
Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol (2006) 3.75
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog (2010) 3.68
In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc Natl Acad Sci U S A (2005) 3.66
Coherent anti-stokes Raman scattering imaging of axonal myelin in live spinal tissues. Biophys J (2005) 3.62
A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell (2013) 3.53
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev (2012) 3.48
ToxoDB: accessing the Toxoplasma gondii genome. Nucleic Acids Res (2003) 3.24
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev (2011) 3.15
A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol (2010) 3.09
Gene density, transcription, and insulators contribute to the partition of the Drosophila genome into physical domains. Mol Cell (2012) 3.08
Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol (2003) 3.02
Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One (2010) 3.02
Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology (2002) 2.96
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol (2012) 2.91
Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity (2004) 2.89
Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity (2009) 2.84
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol (2009) 2.84
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res (2011) 2.71
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci U S A (2007) 2.70
A highly sensitive CMOS digital Hall sensor for low magnetic field applications. Sensors (Basel) (2012) 2.69
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood (2006) 2.69
Targeted drug delivery to tumors: myths, reality and possibility. J Control Release (2011) 2.69
Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet (2010) 2.67
Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol (2010) 2.67
Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res (2009) 2.65
Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A (2005) 2.65
Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis (2009) 2.62
A review of EPAP nasal device therapy for obstructive sleep apnea syndrome. Sleep Breath (2014) 2.61
Vibrational imaging of lipid droplets in live fibroblast cells with coherent anti-Stokes Raman scattering microscopy. J Lipid Res (2003) 2.59
Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med (2004) 2.59
The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol (2008) 2.57
Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57
A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun (2005) 2.55
The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell (2005) 2.53
Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50
AILUN: reannotating gene expression data automatically. Nat Methods (2007) 2.47
Gold Nanorods Mediate Tumor Cell Death by Compromising Membrane Integrity. Adv Mater (2007) 2.46
High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer (2008) 2.46
1,1'-[(Hexane-1,6-diyldi-oxy)bis-(nitrilo-methyl-idyne)]dinaphthalene. Acta Crystallogr Sect E Struct Rep Online (2008) 2.45
Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med (2005) 2.42
Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. Dev Cell (2013) 2.39
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol (2006) 2.39
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol (2011) 2.38
Diethyl 3,8-dimethyl-4,7-diazadeca-2,8-dienedioate. Acta Crystallogr C (2004) 2.38
HIV/STD stigmatization fears as health-seeking barriers in China. AIDS Behav (2006) 2.37
PlasmoDB: the Plasmodium genome resource. An integrated database providing tools for accessing, analyzing and mapping expression and sequence data (both finished and unfinished). Nucleic Acids Res (2002) 2.37
Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34
Inflammation in acute kidney injury. Nephron Exp Nephrol (2008) 2.32
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol (2011) 2.27
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A (2007) 2.27
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol (2011) 2.27
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell (2008) 2.26
2,2-Dimethyl-2,3-dihydro-1-benzofuran-7-yl N-ethyl-carbamate. Acta Crystallogr Sect E Struct Rep Online (2009) 2.24
Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol (2006) 2.22
Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond) (2007) 2.20
Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol (2009) 2.18
The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network. Cell Stem Cell (2012) 2.17
Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches. Blood (2006) 2.14
Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials (2009) 2.13
Differences between left and right ventricular chamber geometry affect cardiac vulnerability to electric shocks. Circ Res (2005) 2.11
Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1. Sci Transl Med (2011) 2.10
Increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas. Int J Urol (2011) 2.07
Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst (2004) 2.06
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet (2011) 2.05